- Home
- TGS vs VKTX Comparison
TGS vs VKTX Comparison
Compare TGS & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGS
- VKTX
- Stock Information
- Founded
- TGS 1992
- VKTX 2012
- Country
- TGS Argentina
- VKTX United States
- Employees
- TGS N/A
- VKTX N/A
- Industry
- TGS Natural Gas Distribution
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- TGS Utilities
- VKTX Health Care
- Exchange
- TGS Nasdaq
- VKTX Nasdaq
- Market Cap
- TGS 3.4B
- VKTX 3.8B
- IPO Year
- TGS N/A
- VKTX 2015
- Fundamental
- Price
- TGS $29.86
- VKTX $37.73
- Analyst Decision
- TGS Strong Buy
- VKTX Strong Buy
- Analyst Count
- TGS 1
- VKTX 14
- Target Price
- TGS $40.00
- VKTX $87.07
- AVG Volume (30 Days)
- TGS 605.6K
- VKTX 4.6M
- Earning Date
- TGS 11-05-2025
- VKTX 10-22-2025
- Dividend Yield
- TGS 3.08%
- VKTX N/A
- EPS Growth
- TGS 59.17
- VKTX N/A
- EPS
- TGS 0.34
- VKTX N/A
- Revenue
- TGS $958,309,969.00
- VKTX N/A
- Revenue This Year
- TGS $47.07
- VKTX N/A
- Revenue Next Year
- TGS N/A
- VKTX N/A
- P/E Ratio
- TGS $19.26
- VKTX N/A
- Revenue Growth
- TGS 7.47
- VKTX N/A
- 52 Week Low
- TGS $19.74
- VKTX $18.92
- 52 Week High
- TGS $34.37
- VKTX $56.25
- Technical
- Relative Strength Index (RSI)
- TGS 60.07
- VKTX 56.93
- Support Level
- TGS $29.27
- VKTX $34.67
- Resistance Level
- TGS $31.65
- VKTX $43.15
- Average True Range (ATR)
- TGS 1.64
- VKTX 2.71
- MACD
- TGS -0.08
- VKTX -0.01
- Stochastic Oscillator
- TGS 38.26
- VKTX 41.57
About TGS Transportadora de Gas del Sur SA TGS
Transportadora de Gas del Sur SA is a transporters of natural gas in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, Production and Commercialization Liquids, Other Services, and Telecommunications. It generates maximum revenue from the Production and Commercialization of the Liquids segment. Geographically, it derives the majority of its revenue from Argentina.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.